Sue Ann Costa Clemens

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Coronavirus Disease

Immune Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Ngigi, Yola Moride, Anne-Marie Castilloux, Sue Ann Costa Clemens
An Interrupted Time Series Analysis of the Impact of the COVID-19 Pandemic on Routine Vaccination Uptake in Kenya. Vaccines 12 (8) (2024)
Wonyeong Jung, Dansu Yuan, Benjamin P Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P McNamara, Sue Ann Costa Clemens
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. NPJ vaccines 9 (1) (2024)
Wonyeong Jung, Dansu Yuan, Benjamin P Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P McNamara, Sue Ann Costa Clemens
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. NPJ vaccines 9 (1) (2024)
Wonyeong Jung, Dansu Yuan, Benjamin P Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Igor Smolenov, Galit Alter, Ryan P McNamara, Sue Ann Costa Clemens
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. NPJ vaccines 9 (1) (2024)